Literature DB >> 9169576

Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography.

K Ishii1, M Sasaki, S Yamaji, S Sakamoto, H Kitagaki, E Mori.   

Abstract

Although decreased posterior cingulate metabolism in Alzheimer's disease (AD) has been previously reported, there have been no reports on posterior cingulate perfusion. In this study we evaluated posterior cingulate perfusion as a relative value using statistical parametric maps (SPMs) and as an absolute value using conventional region of interest (ROI) settings. Twenty-eight subjects, including 14 patients with mild AD (mean age: 66.4+/-12.1 years) and 14 normal controls (65.9+/-7.3 years) were studied. Regional cerebral blood flow (CBF) was measured with H215O and positron emission tomography (PET). In the SPM analysis, the left posterior cingulate and left parietotemporal CBFs were significantly decreased in the patients with mild AD (P<0.001). At a lower statistical threshold (P<0.05), the right posterior cingulate and right parietotemporal CBFs were also significantly decreased in the AD patients. In the ROI studies, the left parietal and posterior cingulate CBFs in the patients with mild AD were significantly lower than those of the normal controls by analysis of variance and post-hoc Scheffé's test (P<0.001). We conclude that posterior cingulate perfusion is decreased in mild AD, reflecting the pathological changes and metabolic reduction in the posterior cingulate gyrus that have previously been reported to occur in mild AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169576     DOI: 10.1007/BF00841407

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections.

Authors:  J H Burdette; S Minoshima; T Vander Borght; D D Tran; D E Kuhl
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

2.  Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET.

Authors:  K Ishii; H Kitagaki; M Kono; E Mori
Journal:  J Nucl Med       Date:  1996-07       Impact factor: 10.057

3.  Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

Authors:  H Fukuyama; M Ogawa; H Yamauchi; S Yamaguchi; J Kimura; Y Yonekura; J Konishi
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Posterior cingulate cortex in Alzheimer's disease.

Authors:  S Minoshima; N L Foster; D E Kuhl
Journal:  Lancet       Date:  1994-09-24       Impact factor: 79.321

6.  A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.

Authors:  H G Gemmell; P F Sharp; J A Besson; K P Ebmeier; F W Smith
Journal:  Eur J Nucl Med       Date:  1988

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Comparability of FDG PET studies in probable Alzheimer's disease.

Authors:  K Herholz; D Perani; E Salmon; G Franck; F Fazio; W D Heiss; D Comar
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

9.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors:  E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

10.  Regional cerebral blood flow, blood volume, oxygen extraction fraction, and oxygen utilization rate in normal volunteers measured by the autoradiographic technique and the single breath inhalation method.

Authors:  J Hatazawa; H Fujita; I Kanno; T Satoh; H Iida; S Miura; M Murakami; T Okudera; A Inugami; T Ogawa
Journal:  Ann Nucl Med       Date:  1995-02       Impact factor: 2.668

  10 in total
  28 in total

1.  Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study.

Authors:  Nabil Maalikjy Akkawi; B Borroni; C Agosti; M Magoni; M Broli; A Pezzini; A Padovani
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

2.  PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for.

Authors:  Kazunari Ishii; Satoshi Minoshima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

3.  Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.

Authors:  Kazunari Ishii; Hiroki Sasaki; Atsushi K Kono; Naokazu Miyamoto; Tetsuya Fukuda; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-31       Impact factor: 9.236

4.  Brain SPET perfusion in early Alzheimer's disease: where to look?

Authors:  Ingeborg Goethals; Christophe Van De Wiele; Daniel Slosman; Rudi Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08       Impact factor: 9.236

5.  Cerebral blood flow MRI in the nondemented elderly is not predictive of post-operative delirium but is correlated with cognitive performance.

Authors:  Tammy T Hshieh; Weiying Dai; Michele Cavallari; Charles Rg Guttmann; Dominik S Meier; Eva M Schmitt; Bradford C Dickerson; Daniel Z Press; Edward R Marcantonio; Richard N Jones; Yun Ray Gou; Thomas G Travison; Tamara G Fong; Long Ngo; Sharon K Inouye; David C Alsop
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Authors:  J Valla; J D Berndt; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

7.  Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease.

Authors:  Guofan Xu; Howard A Rowley; Gaohong Wu; David C Alsop; Ajit Shankaranarayanan; Maritza Dowling; Bradley T Christian; Terrence R Oakes; Sterling C Johnson
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

8.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Authors:  Nikolaos Scarmeas; Christian G Habeck; Eric Zarahn; Karen E Anderson; Aileen Park; John Hilton; Gregory H Pelton; Matthias H Tabert; Lawrence S Honig; James R Moeller; Davangere P Devanand; Yaakov Stern
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

9.  Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity.

Authors:  Jinsoo Uh; Kelly Lewis-Amezcua; Kristin Martin-Cook; Yamei Cheng; Myron Weiner; Ramon Diaz-Arrastia; Michael Devous; Dinggang Shen; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2009-02-05       Impact factor: 4.673

10.  Vascular health risks and fMRI activation during a memory task in older adults.

Authors:  Meredith N Braskie; Gary W Small; Susan Y Bookheimer
Journal:  Neurobiol Aging       Date:  2008-10-01       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.